2023
Half Year 2023 Financial Report XBRL Package
Half Year 2023 Financial Report
First quarter 2023 results
2022 Shareholder annual report
Shares & voting rights 2023
Share repurchases - January 2023
Our Position on Science
Our Position on Planet & Health
Our Position on Manufacturing & Supply Excellence
Our Position on Diversity, Equity & Inclusion
Our Position on Access
2022
Fourth quarter and full year 2022 results
Share repurchases - December 2022
Third quarter 2022 results
Second quarter 2022 results
Our Integrated Report 2022
First quarter 2022 results
Letter to Shareholders (March 2022)
Annual Report on Form 20-F 2022
2022 declaration of extra financial performance (ESG Report)
Shares & voting rights 2022
Share repurchases - January 2022
Half Year 2022 Financial Report
Registration document 2022 (in French)
2021
Fourth quarter and full year 2021 results
Letter to shareholders (December 2021)
Share repurchases - December 2021
Third quarter 2021 results
Second quarter 2021 results
First quarter 2021 results
Letter to shareholders (April 2021)
Shares & voting rights 2021
Share repurchases - January 2021
Our Integrated Report 2021
Half Year 2021 Financial Report
Annual Report on Form 20-F 2021
2021 declaration of extra financial performance (ESG Report)
Registration document 2021 (in French)
2020
Fourth quarter and full year 2020 results
Letter to shareholders (December 2020)
Share repurchases - December 2020
Share repurchases - November 2020
Third quarter 2020 results
Letter to shareholders (August 2020)
Second quarter 2020 results
First quarter 2020 results
Share repurchases - February 2020
Shares & voting rights 2020
Share repurchases - January 2020
At the heart of Sanofi
Integrated Report 2020
Half-Year Financial Report 2020
Annual Report on Form 20-F 2020
2020 declaration of extra financial performance (ESG Report)
Registration document 2020 (in French)
2019
Fourth quarter and full year 2019 results
Third quarter 2019 results
Second quarter 2019 results
First quarter 2019 results
Share repurchases - April 2019
Letter to shareholders (March 2019)
Shares & voting rights 2019
At the heart of Sanofi
Integrated Report 2019
Annual Report on Form 20-F 2019
Half-Year Financial Report 2019
2019 declaration of extra financial performance (ESG Report)
Registration document 2019 (in French)
2018
Fourth quarter and full year 2018 results
Letter to shareholders (December 2018)
Share repurchases - November 2018
Third Quarter 2018 Results
Share repurchases - October 2018
Share repurchases - September 2018
Letter to shareholders (September 2018)
Share repurchases - August 2018
Second quarter 2018 results
Share repurchases - July 2018
Share repurchases - June 2018
Letter to shareholders (June 2018)
First quarter results 2018
Letter to shareholders (March 2018)
Share repurchases - February 2018
Share repurchases - January 2018
Annual Report on Form 20-F 2018
Half-Year Financial Report 2018
2018 declaration of extra financial performance (ESG Report)
XBRL package 2018
Registration document 2018 (in French)
Shares & voting rights 2018
Letter to shareholders (January 2018)
2017
Letter to shareholders (September 2017)
Letter to shareholders (June 2017)
Half-Year Financial Report 2017
Annual Report on Form 20-F 2017
XBRL package 2017
Registration document 2017 (in French)
2016
Half-Year Financial Report 2016
Annual Report on Form 20-F 2016
Registration document 2016 (in French)
2015
Annual Report on Form 20-F 2015
Half-Year Financial Report 2015
Registration document 2015 (in French)
2014
Half-Year Financial Report 2014
Annual Report on Form 20-F 2014
Registration document 2014 (in French)
2013
Annual Report on Form 20-F 2013
Half-Year Financial Report 2013
Registration document 2013 (in French)